Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab

Felicia Stefania Falvella, C. Cremolini, R Miceli, F. Nichetti, Stefania Cheli, C. Antoniotti, G. Infante, A Martinetti, Federica Marmorino, E Sottotetti, R Berenato, M Caporale, A Colombo, F de Braud, M Di Bartolomeo, E Clementi, F Loupakis, F Pietrantonio

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences